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Abstract
Purpose This laboratory-based investigation compares the to-
pographic outcomes of conventional penetrating keratoplasty
with that of a novel procedure in which donor corneas are
cross-linked prior to keratoplasty.
Methods Penetrating keratoplasty procedures with continuous
running sutures were carried out in a porcine whole globe
model. Sixty eyes were randomly paired as ‘donor’ and ‘host’
tissue before being assigned to one of two groups. In the cross-
linked group, donor corneas underwent riboflavin/UVA cross-
linking prior to being trephined and sutured to untreated hosts.
In the conventional keratoplasty group, both host and donor
corneas remained untreated prior to keratoplasty. Topographic
and corneal wavefront measurements were performed follow-
ing surgery, and technical aspects of the procedure evaluated.
Results Mean keratometric astigmatism was significantly
lower in the cross-linked donor group at 3.67D (SD 1.8 D),
vs. 8.43 D (SD 2.4 D) in the conventional keratoplasty group
(p<0.005). Mean wavefront astigmatism was also significant-
ly reduced in the cross-linked donor group 4.71 D (SD 2.1) vs.
8.29D (SD 3.6) in the conventional keratoplasty group
(p<0.005). Mean RMS higher order aberration was signifi-
cantly lower in the cross-linked donor group at 1.79 um (SD
0.98), vs. 3.05 um (SD 1.9) in the conventional keratoplasty
group (P=0.02). Qualitative analysis revealed less tissue dis-
tortion at the graft-host junction in the cross-linked group.
Conclusion Cross-linking of donor corneas prior to kerato-
plasty reduces intraoperative induced astigmatism and aberra-
tions in an animal model. Further studies are indicated to eval-
uate the implications of this potential modification of kerato-
plasty surgery.
Keywords Keratoplasty . Corneal cross-linking . Riboflavin/
UVA cross-linking
Introduction
Corneal transplant or keratoplasty procedures are well
recognised in the management of axial opacity of the cornea
to restore vision [1]. Both penetrating keratoplasty (PKP),
where the full thickness of the cornea is replaced, and deep
anterior lamellar keratoplasty (DALK), where only the anteri-
or corneal layers are replaced, are established and successful
procedures. However, the visual and refractive outcomes are
suboptimal, with only about one third of PKP achieving 6/6 or
better corrected vision [1–4]. In the case of DALK these out-
comes in large series appear slightly worse or at best compa-
rable [2, 5]. The dominant cause of limited visual outcome
following PKP and DALK is the induction of regular and
irregular astigmatism [3, 4, 6]; this has been elegantly demon-
strated by the improvement in vision granted by adaptive op-
tical correction [7]. Various refinements of surgical technique
over the past decades have been developed to address kerato-
plasty astigmatism, with varying success. Subsequent surgical
or laser correction of irregularity may also be performed [8]. A
proportion of cases benefit from the use of rigid contact lenses
to correct irregularities of the anterior refracting surface [8].
However, even with these interventions, visual limitation re-
mains significant [7, 8].
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Corneal cross-linking using UVA-activated riboflavin is a
relatively recent but established procedure for the prevention
of progression of corneal ectasia due to keratoconus [9]. The
treatment, which stiffens the corneal stroma by induction of
chemical cross-links, has been revealed to prevent progression
in the majority, as well as improve topographic parameters in a
subset of keratoconic corneas [10]. Within the limitations of
these studies, corneal cross-linking appears to have a signifi-
cant and lasting effect on corneal biomechanical parameters.
The induction of regular and irregular astigmatism in the
visual axis of transplanted donor corneas is a function of a
number of biomechanical considerations, particularly related
to the alignment and tension along the point of attachment to
the donor, i.e., the graft-host interface. Anymismatch between
the shape of donor and host trephination will result in induc-
tion of irregularity [8, 11, 12]. Sutures are used to approximate
the interface but may vary in tension, length, depth, alignment
and spacing. Each of these variables at the graft-host junction
in turn has an effect on the axial cornea by inducing irregular
and regular astigmatism. In the case where the host cornea
itself is irregular, particularly in ectasias, this further induces
variable force and, hence, shapes at the visual axis of the
donor [11, 12].
Given these considerations, we hypothesized that it might
be expected that the induction of irregular and regular astig-
matism within the donor cornea may be inversely related to
the modulus of elasticity, in such a way that a more easily
deformable donor cornea would be expected to exhibit higher
levels of induced regular and irregular astigmatism than a
stiffer donor cornea. If this were the case, we further hypoth-
esized that increasing the stiffness of the donor cornea, by
cross-linking it prior to keratoplasty, may result in a reduction
of induced central regular and irregular astigmatism. If so, this
novel procedure might provide a simple means to mitigate
some of the visually limiting irregularity in corneal transplan-
tation procedures.
Materials and methods
The animal experiments in this paper comply with the
Principles of Laboratory Animal Care (NIH publication No.
85–23, revised 1985), the OPRR Public Health Service Policy
on the Humane Care and Use of Laboratory Animals (revised
1986), and the U.S. Animal Welfare Act, as amended, as well
as specific national laws.
Sixty fresh porcine eyes were collected within 3 h of death
from animals slaughtered for non-research purposes in an EC
licensed abattoir (Maddock Kembrey Meats Ltd. Maesteg,
UK). Thirty eyes were designated as ‘donor’ tissue and the
remaining 30 eyes as ‘host’ tissue. The donor and host eyes
were randomly paired and allocated into two groups. In the
cross-linked group, the donor cornea was de-epithelialized
and immersed in commercial riboflavin 0.1 % with dextran
20 % solution (Mediocross, Peshke Meditrade GmBH,
Boesch, Switzerland), for between 30 min and 12 h. The do-
nor eyes in the conventional keratoplasty group were also de-
epithelialized and simultaneously immersed in 20 % dextran
T500 solution (Pharmacosmos, Holbaek, Denmark). Host
eyes were prepared identically to the conventional donor eyes.
All eyes were maintained in a light-excluded environment
during this phase to prevent inadvertent cross-linking of the
riboflavin-treated corneas. In keeping with the conventional
protocol for in vivo cross-linking of keratoconus corneas [9],
the cross-linked donor group was then exposed to 3 mW/cm2
UVA light for 30 min using a commercially available cross-
linking lamp (CCL Vario Crosslinker, Peshke Meditrade
GmBH, Boesch, Switzerland). During the cross-linking pro-
cedure, riboflavin eye drops were applied every 5 min. During
the corresponding period, the donor corneas in the conven-
tional keratoplasty group and the host corneas were main-
tained at ambient temperature and not exposed to any light.
A keratoplasty procedure was subsequently performed for
both groups (15 cross-linked donor keratoplasties and 15 stan-
dard untreated donor keratoplasties). All keratoplasty proce-
dures in the study were carried out by a single surgeon (AM).
Both donor and host globes were trephined using a 7.5 mm
freehand corneal trephine and completed with corneal scis-
sors. Sodium hyaluronate 1 % viscoelastic (Provisc, Alcon,
Fort Worth, USA) was applied to maintain the anterior cham-
ber and donors from both groups that were sutured using a
standardised continuous single running 10/0 nylon suture with
16 bites under microscopic visualisation. No suture adjust-
ment or keratoscopic visualisation was performed to avoid
operator bias. In order to avoid distortion of topography in-
duced by viscoelastic, this was aspirated via a small
paracentesis and replaced with balanced salt solution (Alcon,
Fort Worth, TX, USA). The globe was then inflated through
this paracentesis to approximately physiological pressure de-
termined digitally. The use of Tono-Pen tonometry (Reichert,
NY, USA) was avoided due to concern that measurement itself
might affect the corneal topography, while Goldmann
applanation tonometry was not technically feasible. A small
amount of artificial tear solution (hypromellose 0.3 %) was
applied to the surface of each cornea to prevent drying and
allow the reliable acquisition of topographic data. The typical
appearance of eyes following cross-linked donor keratoplasty
and conventional keratoplasty is shown in Fig. 1c and d,
respectively.
Topography of the transplanted corneas was performed
using a vertically mounted, intraoperative, high resolution,
small cone placido topographer (Keratron Scout, Optikon
SpA, Rome, Italy). To prevent distortion of the eyes during
measurement, the globes were carefully mounted in a corneal
viewing chamber (with the cornea facing upwards). The eyes
were then rotationally aligned using the position of insertion
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of the extraocular muscles, and manually aligned with the red
reflex to maintain axial orientation prior to measurement.
Measurements were repeated six times for each specimen.
The automated software was used to centre the horizontal
alignment prior to capture. Following capture, the three read-
ings with the least traceable ring images were discarded, and
the remainder analysed. Automated analysis of topographic
parameters and map were carried out, as well as corneal
wavefront analysis of higher order aberrations including peak
to valley (PV) and root mean square (RMS) values.
Results
Simulated keratometry
Simulated keratometry values derived from the topography
were analysed. Mean Keratometric value was 30.9 D (SD
5.9 D; range 22 .8 to 44.5 D) in the cross-linked donor group
and 34.6 D (SD 8.9 D; range 21.1 to 46.0 D) in the conven-
tional keratoplasty group. There was no significant difference
between groups (P=0.209t-test).
Keratoplasty astigmatism
Astigmatism values were derived from the simulated
keratometry and from the wavefront measurement and com-
pared between groups. Mean keratometric astigmatism was
3.67D (SD 1.8 D range 0.45 to 6.37 D) in the cross-linked
donor group, and 8.43 D (SD 2.4 D, range 4.7 to 12.6 D) in the
conventional keratoplasty group. Keratometric mean astigma-
tism was significantly lower in the cross-linked donor group
(p<0.005t-test). Astigmatic measurement was also derived
from the wavefront analysis, since this is a composite value
derived across the assessment area, and may provide a more
accurate assessment in highly irregular or aberrated corneas.
Meanwavefront astigmatismwas 4.71 D (SD 2.1; range 0.6 to
8.8) in the cross-linked donor group, and 8.29D (SD 3.6 D;
range 2.1 to 14.7 D) in the conventional keratoplasty group.
The mean wavefront astigmatism was also significantly lower
in the cross-linked donor group (p<0.005t-test) (Fig. 2).
Higher order aberrations
The corneal wavefront measurement was performed using the
inbuilt software of the topographer derived from the placido
ring data. Centration of the corneal wavefront map was select-
ed on the geometric centre of the donor as pupil-centered
assessment was neither relevant to the current study nor tech-
nically feasible. Analysis was performed over an area of di-
ameter 4.5 mm to assess the axial part of the donor cornea.
Mean RMS wavefront aberration in the cross-linked donor
group was 1.79 um (SD 0.98 range 0.67 to 4.34 um), while
it was 3.05 um (SD 1.9 range 0.8 to 6.5 um) in the conven-
tional keratoplasty group. RMS aberration was significantly
lower in the cross-linked donor group (P=0.02, t-test). Mean
P-Vaberration was 11.4 um (SD 6.7 range 4.1 to 29.9 um) in
the cross-linked donor group and 23.4 um (SD 17.8 um range
5.3 to 57 um) in the conventional keratoplasty group, signif-
icantly lower in the cross-linked donor group (P=0.029t-test).
Both coma and spherical aberration were independently
analysed due to the visual relevance post keratoplasty. Mean
coma aberration in the cross-linked and conventional kerato-
plasty groups was 1.01 um (SD 0.6, range 0.3 to 2.4 um) vs.
0.75 um (SD 0.67 range 0.1 to 2.3 um), while mean spherical
aberration was −0.26 um (SD 0.5 range −1.4 to 0.3 um) vs.
−0.09 um (SD 0.57 range −1.6 to 0.6 um), respectively.
Neither coma nor spherical aberration differed significantly
between groups (P=0.3, P=0.5, respectively) (Fig. 3).
Qualitative analysis
Topographic maps were additionally analysed qualitatively. In
particular, the pattern of ring images at the graft-host junction
was evaluated since the reflex in this area was beyond the
range of automated assessment by the topographer. There
was a distinct dissimilarity noted between cross-linked and
non-cross-linked donors. At the graft-host junction, the local
distortion of placido reflex due to compression by each suture
bite was a subjectively larger in terms of area and magnitude
in the conventional keratoplasty donors, compared to the
cross-linked donors. There was also a localised ring of steep-
ening in a ‘doughnut’ shape, in the sutured area of conven-
tional keratoplasty donors, which was largely absent in the
cross-linked cases. A typical representative sample of ring
images from conventional and cross-linked donors is present-
ed in Fig. 4a–d and e–h, respectively.
Fig. 1 Photographs of a cross-linked (a) and conventional donor (b)
globe prior to trephination, after cross-linked donor keratoplasty (c) and
after conventional donor keratoplasty (d)
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Surgical observations
Due to the altered appearance of the cross-linked donor cor-
neas, the surgical operators could not be blinded to the donor
group. A number of observations were made in relationship to
the surgical aspects of keratoplasty in cross-linked versus con-
ventional donors. Alignment and approximation of the sutured
edges was much easier in the cross-linked group, since the
tissue was more resistant to deformation and maintained shape
during the passage of the needle. This was particularly notice-
able during passage of the cardinal suture bites, where align-
ment can be challenging in keratoplasty procedures as the
donor tissue is not yet fixed in place. There was a slightly
increased resistance to the passage of the needle and suture
in the cross-linked group, but this did not affect the ease of
surgery. Achieving a watertight wound was also easier in the
cross-linked group, since there was less distortion on applica-
tion of suture tension and the wound was less affected by
suture positioning and alignment. One negative aspect with
the cross-linked donor keratoplasty procedure was the tenden-
cy to override the host tissue if vertically misaligned or over
tightened, since, unlike in conventional keratoplasty donors,
the compressed edge did not broaden under tension, while the
host edge was deformed.
Discussion
The primary objective of this study was to evaluate the possi-
bility of reducing regular and irregular astigmatism and aber-
rations by cross-linking donor corneas prior to keratoplasty.
To our knowledge this is the first report to evaluate corneal
cross-linking of donor corneas for keratoplasty. The findings
of this study support the hypothesis that altering the biome-
chanical rigidity of a keratoplasty donor may reduce the in-
duced regular and irregular astigmatism of the axial refracting
surface by lessening the effect of forces at the graft host
junction.
We thus found significantly reduced values for all parame-
ters evaluating regular astigmatism: simulated keratometry, as
well as more composite geometric measures including
Maloney best fit cylinder, and the reconstructed corneal
Fig. 2 Graph comparing
keratometric, wavefront, and
Maloney best fit astigmatism
between cross-linked donor
corneas and conventional donors
undergoing penetrating
keratoplasty
Fig. 3 Graph comparing higher
order aberrations (μm) and
Maloney irregularity index
between cross-linked donor
corneas and conventional donors
undergoing penetrating
keratoplasty
2226 Graefes Arch Clin Exp Ophthalmol (2015) 253:2223–2228
wavefront astigmatism. All of these suggest that cross-linking
the donor cornea may indeed reduce the regular astigmatism
induced during a keratoplasty procedure. The magnitude of
this effect was somewhat unexpected prior to commencing the
study, since our expectation was that cross-linking would sig-
nificantly reduce local changes in shape, by evenly distribut-
ing forces, and, thus, have an effect mainly on irregular astig-
matism and high order aberrations, rather than reducing regu-
lar astigmatism. Nonetheless, the donor cross-linking proce-
dure had a marked effect on regular astigmatism, with a re-
duction of less than half in all measured parameters. It is also
noteworthy that no suture adjustment or intraoperative
keratometry was performed, as would be usual in such proce-
dures, thus, the level of astigmatism overall might be expected
to be lower still if applied to clinical procedures.
Our primary motivation for developing the procedure how-
ever, was more to address irregular astigmatism and high or-
der aberrations. These are a significant issue affecting visual
outcomes of keratoplasty procedures, since they are not easily
corrected and relate to the limited visual outcomes in a signif-
icant proportion of cases. RMS and P-V measures of HOA
were significantly reduced to approximately one half and one
third respectively of the values in the conventional keratoplas-
ty group. The Maloney topographic irregularity index was
also significantly lower in the cross-linked donors. These
changes would be expected to lead to considerably better vi-
sual outcomes if mirrored in human keratoplasty procedures.
A secondary objective was to assess whether cross-
linking would require any alteration of the surgical tech-
nique for keratoplasty. However the procedure required no
significant changes to technique and was, if anything, eas-
ier to perform using cross-linked donors as alignment and
placement of suture passes in more rigid tissue was simpler.
The potential override of donor was easily avoided by at-
tention to suture depth. In this regard, matched trephination
techniques such as femtosecond laser trephination might be
of particular benefit.
The main limitation of this study is the applicability of
findings to a proposed human surgical procedure due to the
biomechanical differences between human donor and porcine
corneas [13]. Human donor corneas are often from older do-
nors, and would be expected to be inherently more cross-
linked physiologically. The porcine corneas, which came from
animals between 6 months and 1 year old, appeared to have a
lower rigidity than a typical human donor cornea in culture. It
is, thus, unclear whether any additional biomechanical stiffen-
ing induced by cross-linking in human keratoplasty proce-
dures would replicate the findings of this study. Human donor
corneas are usually harvested as corneoscleral rims rather than
whole globes, which may alter the corneal curvature, thus
warranting planned further human donor cornea studies. The
possibility that intraocular pressure variation affected the mea-
surements to some degree cannot be excluded as accurate
measurement was not performed for technical reasons.
Nonetheless, there is no reason to expect any groupwise bias,
nor would this factor be likely to explain the changes noted. A
further potential bias is the un-blinded nature of the proce-
dures, as it was not technically feasible to carry out kerato-
plasty without being aware of the cross-linked state. In order
to limit the effects of this potential bias, the surgical protocol
avoided any intraoperative keratometry or suture adjustment,
limiting the effects of surgical bias on outcomes. The ultimate
outcome of keratoplasty procedures in this regard can only be
determined by an in vivo study following suture removal.
Fig. 4 Representative placido ring images after penetrating keratoplasty with conventional donors (a–d) and cross-linked donors (e–h). A reduced area
of distortion around the graft host interface is noted in cross-linked donors, with a more regular reflex and better quality ring images overall
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Although the effects of donor cross-linking on keratoplasty
have not been evaluated previously, cross-linking has previously
been applied in the setting of existing keratoplasty without con-
cern. Spadea and Paroli investigated combined photorefractive
keratectomy and cross-linking after lamellar keratoplasty in 14
eyes, with no noted adverse effect at a mean of 15 months [6].
Labiris et al. applied cross-linking to an infected penetrating
keratoplasty with no noted adverse effect [14]. Kanellopoulous
performed crosslinking of donor vehicle for Boston keratopros-
thesis with no issues [15]. There may be potential concern for
injury to the donor endotheliumwhen cross-linking is applied to
donor corneas. However, endothelial injury would theoretically
be very unlikely as donor corneas are typically thicker than in
the physiological state, and the procedure has been shown to be
safe above 400 μm. Nonetheless, safety studies in human donor
corneas would be advisable before any application of the study
procedure to human keratoplasty. Keratoplasty has also been
successfully carried out on previously cross-linked eyes [16].
A modified cross-linking procedure to enhance graft-host adhe-
sion has previously been described in a laboratory model for
femtosecond keratoplasty; however, this is unrelated to the tech-
nique we propose, since the donor was not cross-linked prior to
keratoplasty and astigmatic outcome would be expected to be
unaffected as the cross-linking is applied after graft alignment
[17]. Cross-linking has also been utilized for biosynthetic cor-
neal tissue engineering [18, 19]. In addition to the biomechani-
cal effect, cross linking depletes keratocytes, and, thus, may
theoretically have beneficial effects with regard to immunolog-
ical rejection[20]. Clearly, further studies are warranted to ascer-
tain whether the potential visual benefits of donor cross-linking
for keratoplasty, as demonstrated here in the porcine eye model,
may be replicated in human keratoplasty surgery.
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